AzTrials
AzTrials

Unexpected Delivery Outside MaternityAIEH34NCT03820505

Observatory of Unintentional Births Hospital Extras

An observational study of Unexpected Delivery Outside Maternity, run by University Hospital, Montpellier at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In France, pre-hospital unexpected birth is a rare situation, but over the last ten years, the investigators have seen an increase in the number of these. For this, the investigators realize an observatory of these deliveries and their care from the call for help and the investigators continue the follow-up and the… Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Unexpected Delivery Outside Maternity
How many people
350 participants
Where
1 siteFrance
Study dates
23 Jan 2019to 28 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Unexpected delivery outside maternity in the Hérault department

Who may be able to join

  • Unexpected delivery outside maternity, presence of a medical team during the care

Who cannot join

  • Absence of medicalization

Trial locations and contacts

1 site in 1 country.

Christelle GRAF, wise woman contact

0677696194 ext. 33

c-graf@chu-montpellier.fr

France1 site, 1 recruiting
  • Uhmontpellier

    Montpellier, 34295

    Christelle GRAF, wise woman, 0677696194 ext. 33, c-graf@chu-montpellier.fr

    Recruiting

Other trials in France

About this study

Official title: Observatory of Unintentional Births Hospital Extras in Hérault

In France, pre-hospital unexpected birth is a rare situation, but over the last ten years, the investigators have seen an increase in the number of these.

For this, the investigators realize an observatory of these deliveries and their care from the call for help and the investigators continue the follow-up and the future of patients and newborns until J7 postpartum.

Read the detailed description

As a result, the investigators also found a very high variability in the number of deliveries per month for the EMS 34 and the SSSM of the SDIS 34, which can reach up to 11 deliveries per month (May 2014 example).

Formalized expert recommendations were published in 2010 by SFAR, which then led to the establishment of a national observatory for IEA at the end of 2011, in which the investigators have been participating for 4 years.

Currently the national database lists 2000 unannounced deliveries including 230 in the Hérault.

This observational study allows us to evaluate the management of these patients and newborns, the risks and needs of pre-hospital teams, including the need for reinforcement and expertise of midwives.

The investigators can also assess mortality and morbidity, as well as the extension of hospital stays beyond J7

Keywords
obstetrics, pre-hospital emergencies unannounced delivery outside maternity,, mortality-morbidity, reinforcement midwife in pre-hospital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of unexpected hospital deliveries (AIE)

    Estimate the impact of non-maternal AIE by the SMUR and the SSM in the department of Héraul, and compare it to the national overall activity

    Measured: DAY 0 TO DAY 7 TO DELIVRERY

Secondary outcomes (4)
  1. Method of taking care of unannounced extra hospital deliveries

    Method of taking care of unannounced extra hospital deliveries

    Measured: DAY 0 TO DAY 7 POST DELIVRERY

  2. Difficulties during an unexpected delivery outside maternity

    Identify the difficulties during an unexpected delivery outside maternity

    Measured: DAY 0 TO DAY 7 POST DELIVRERY

  3. Risks during an unexpected delivery outside maternity

    Identify the risks during an unexpected delivery outside maternity

    Measured: DAY 0 TO DAY 7 POST DELIVRERY

  4. Possible immediate complications during an unexpected delivery outside maternity

    Identify the possible immediate complications during an unexpected delivery outside maternity

    Measured: DAY 0 TO DAY 7 POST DELIVRERY

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2019
  2. Study start23 Jan 2019
  3. Primary completion1 Feb 2022 (estimated)
  4. Study completion28 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
350 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03820505
Sponsor's protocol ID
RECHMPL18_0442
Acronym
AIEH34
Status last verified
Mar 2020
First submitted
23 Jan 2019
Last updated
10 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Unexpected Delivery Outside Maternity, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christelle GRAF, wise woman (0677696194 ext. 33, c-graf@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of unexpected hospital deliveries (AIE) (time frame: DAY 0 TO DAY 7 TO DELIVRERY). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in